Emyria ASX Announcement | 7 September2026 1 ASX RELEASE. 7 September 2026 REVISED SECURITIES TRADING POLICY Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) advises that it has revised its Securities Trading Policy, a copy of which is attached for release to the market....
Revised Securities Trading Policy
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Emyria
- Appendix 4E & Annual Financial Report Year End 30 June 2026
- 2026 Annual General Meeting - Key Dates
- Emyria Unlocks Treatment Capacity
- Notification of cessation of securities - EMD
- Change of Registered Office and Principal Place of Business
Later from Emyria
- Emyria Financial Year-end Update Webinar
- Emyria Year End Presentation for Investor Webinar
- Emyria Set to Launch First NSW Clinic
- FDA Selects EMD to Present at Psychedelic Medicines Hearing
- Emyria Presentation at FDA Hearing
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria